3D LifePrints raises £1.2 million to advance medical 3D printing offerings
Summary
Led by Fenwall Investments the £1.2 million in finance will hasten the award-winning medical 3D printing enterprises’ presence in the local and international market. With the newly announced funding, 3D LifePrints plans to bring the hub model to more cities in the UK, specifically London, Birmingham, Manchester, and Leeds. Paul Fotheringham, Founder and CTO for 3D LifePrints said “We are extremely pleased to announce the completion of this funding round with investment from Fenwall Investments and a number of individual investors, and will continue to develop our unique business model of providing embedded 3D medical printing services in order to drive down operational costs, provide innovative 3D technology-based products and services, and ultimately improve patient care” Henry Pinchbeck, Co-Founder, and CEO for 3D LifePrints said “I’m delighted that Fenwall are re-investing in us. They are a perfect long-term partner for 3D LifePrints, with a shared set of values and a vision for improving healthcare across the globe” Dr. Andrew Douglas, Managing Director of Fenwall Investments Ltd said “We’re delighted to be on board with this talented team operating in an emerging and fast-developing market. I’m looking forward to an exciting and profitable partnership.” Are you in the medical sector or interested in how 3D printing can assist in the Coronavirus pandemic?